Edge Wealth Management LLC Abb Vie Inc. Transaction History

Edge Wealth Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$131.98 - $163.75 $128,020 - $158,837	-970 Closed	0 $0
Q3 2021 Oct 13, 2021	BUY	$106.4 - $120.78 $4,149 - $4,710	39 Added 4.19%	970 $105,000
Q1 2021 Apr 09, 2021	BUY	$102.3 - $112.62 $4,910 - $5,405	48 Added 5.44%	931 $101,000
Q3 2020 Oct 21, 2020	SELL	$85.91 - $100.83 $55,841 - $65,539	-650 Reduced 42.4%	883 $77,000
Q2 2020 Aug 03, 2020	BUY	$73.37 - $98.18 $23,771 - $31,810	324 Added 26.8%	1,533 $151,000
Q1 2020 Apr 20, 2020	BUY	$64.5 - $97.79 $25,800 - $39,116	400 Added 49.44%	1,209 $93,000
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $17,022 - $21,299	236 Added 41.19%	809 $71,000
Q3 2019 Oct 21, 2019	BUY	$62.98 - $75.72 $18,579 - $22,337	295 Added 106.12%	573 $43,000
Q2 2019 Jul 15, 2019	BUY	$65.7 - $83.98 $18,264 - $23,346	278 New	278 $20,000
Q2 2018 Jul 17, 2018	SELL	$89.78 - $106.23 $89,780 - $106,230	-1,000 Closed	0 $0
Q1 2018 Apr 05, 2018	BUY	$92.01 - $123.21 $82,809 - $110,889	900 Added 900.0%	1,000 $95,000
Q4 2017 Jan 18, 2018	BUY	$89.56 - $98.21 $8,956 - $9,821	100	100 $9,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.